Otros idiomas CRISPR Therapeutics AG

Acciones

CRSP

CH0334081137

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 14/05/2024			Varia. Cinco días.	Varia. 1 de enero.
55,71 ^USD	+0,11 %		+0,32 %	-11,01 %

10/05	CRISPR THERAPEUTICS AG : recomendación de compra de Oppenheimer	ZM
09/05	CRISPR THERAPEUTICS AG : Obtiene una recomendación neutral de Barclays	ZM

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference	09/05
CRISPR Therapeutics AG Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
Earnings Flash (CRSP) CRISPR THERAPEUTICS AG Reports Q1 Revenue $504,000	08/05
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results	08/05
CRISPR Therapeutics : ASGCT 2024 Oral Presentation	08/05
CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo Gene Editing Approach	08/05
CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing in Vivo Gene Editing Approach	08/05
CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene and Cell Therapy 2024 Annual Meeting	23/04
CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting	22/04
Crispr Therapeutics Insider Sold Shares Worth $1,173,232, According to a Recent SEC Filing	17/04
Harvard University: How to realize immense promise of gene editing	17/04
CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conference	03/04
CRISPR Therapeutics to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting	01/04
Recent Appellate Decision Overturns Revocations Of Broad Institute CRISPR-Cas9 Patents	26/03
CRISPR Therapeutics Proposes New Appointment to the Board of Directors	13/03
CRISPR Therapeutics Swings to Q4 Profit, Revenue Increases	21/02
CRISPR Therapeutics AG Reports Earnings Results for the Full Year Ended December 31, 2023	21/02
Earnings Flash (CRSP) CRISPR THERAPEUTICS AG Reports Q4 Revenue $201.2M	21/02
Earnings Flash (CRSP) CRISPR THERAPEUTICS AG Posts Q4 EPS $1.10	21/02
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results	21/02

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas CRISPR Therapeutics AG

Acciones

CRSP

CH0334081137

Otros idiomas

Filtros